Leukocyte heterogeneity in pancreatic ductal adenocarcinoma: phenotypic and spatial features associated with clinical outcome

Cancer Statistics, 2021

Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522 · see citing works

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810 · see citing works

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645 · see citing works

Understanding the tumor immune microenvironment (TIME) for effective therapy

Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145 · see citing works

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,172 · see citing works

The immune contexture in human tumours: impact on clinical outcome

Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · see citing works

Molecular and cellular insights into T cell exhaustion

Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652 · see citing works

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A. C., Raoul, J.-L., Choné, L., Francois, E., Artru, P., Biagi, J. J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809775 · Cited by 2,874 · see citing works

B cells and tertiary lymphoid structures promote immunotherapy response

Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731 · see citing works

Macrophages as regulators of tumour immunity and immunotherapy

DeNardo, D. G., & Ruffell, B. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,542 · see citing works

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Cabrita, R., Lauss, M., Sanna, A., Donia, M., Skaarup Larsen, M., Mitra, S., Johansson, I., Phung, B., Harbst, K., Vallon-Christersson, J., et al. (2020) · Nature · doi:10.1038/s41586-019-1914-8 · Cited by 2,374 · see citing works

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Pagès, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C., Lugli, A., Zlobec, I., Rau, T. T., Berger, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30789-x · Cited by 2,075 · see citing works

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 1,973 · see citing works

B cells are associated with survival and immunotherapy response in sarcoma

Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1906-8 · Cited by 1,942 · see citing works

Tertiary lymphoid structures in the era of cancer immunotherapy

Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884 · see citing works

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715 · see citing works

Defining ‘T cell exhaustion’

Blank, C. U., Haining, W. N., Held, W., Hogan, P. G., Kallies, A., Lugli, E., Lynn, R. C., Philip, M., Rao, A., Restifo, N. P., et al. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0221-9 · Cited by 1,603 · see citing works

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

Initiative, A. P. C. G., Balachandran, V. P., Łuksza, M., Zhao, J. N., Makarov, V., Moral, J. A., Remark, R., Herbst, B., Askan, G., Bhanot, U., et al. (2017) · Nature · doi:10.1038/nature24462 · Cited by 1,191 · see citing works

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

Keren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S.-R., Kurian, A., Van Valen, D., West, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.039 · Cited by 1,183 · see citing works

Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms

Beltra, J., Manne, S., Abdel-Hakeem, M. S., Kurachi, M., Giles, J. R., Chen, Z., Casella, V., Ngiow, S. F., Khan, O., Huang, Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.014 · Cited by 1,091 · see citing works

Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer

Ino, Y., Yamazaki–Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 853 · see citing works

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

Carstens, J. L., Correa de Sampaio, P., Yang, D., Barua, S., Wang, H., Rao, A., Allison, J. P., LeBleu, V. S., & Kalluri, R. (2017) · Nature Communications · doi:10.1038/ncomms15095 · Cited by 633 · see citing works

Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes

Lin, J.-R., Izar, B., Wang, S., Yapp, C., Mei, S.-L., Shah, P., Santagata, S., & Sorger, P. (2018) · eLife · doi:10.7554/elife.31657 · Cited by 631 · see citing works

Pancreatic cancer: from state-of-the-art treatments to promising novel therapies

Garrido‐Laguna, I., & Hidalgo, M. M. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.53 · Cited by 565 · see citing works

Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis

Tsujikawa, T., Kumar, S., Borkar, R. N., Azimi, V., Thibault, G., Chang, Y. H., Balter, A. I., Kawashima, R., Choe, G. H., Sauer, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.037 · Cited by 555 · see citing works

Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation

Lutz, E. R., Wu, A. A., Bigelow, E. O., Sharma, R. B., Mo, G., Soares, K. C., Solt, S., Dorman, A., Wamwea, A., Yager, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0027 · Cited by 551 · see citing works

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer

Steele, N. G., Carpenter, E. S., Kemp, S. B., Sirihorachai, V. R., The, S., Delrosario, L., Lazarus, J., Amir, E.-A. D., Gunchick, V., Espinoza, C. E., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00121-4 · Cited by 546 · see citing works

Immunotherapy and Prevention of Pancreatic Cancer

Morrison, A. H., Byrne, K. T., & Vonderheide, R. H. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.04.001 · Cited by 469 · see citing works

A Novel Lysosome-Associated Membrane Glycoprotein, DC-LAMP, Induced upon DC Maturation, Is Transiently Expressed in MHC Class II Compartment

de Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin, J., Aït‐Yahia, S., Patel, S., Mattéi, M., Banchereau, J., Zurawski, S., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80615-9 · Cited by 399 · see citing works

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer

Hiraoka, N., Ino, Y., Yamazaki–Itoh, R., Kanai, Y., Kosuge, T., & Shimada, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.145 · Cited by 364 · see citing works

Priming of naive T cells inside tumors leads to eradication of established tumors

Yu, P., Lee, Y., Liu, W., Chin, R., Wang, J. H., Wang, Y., Schietinger, A., Philip, M., Schreiber, H. W., & Fu, Y. (2004) · Nature Immunology · doi:10.1038/ni1029 · Cited by 356 · see citing works

Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer

Blando, J., Sharma, A., Higa, M. G., Zhao, H., Vence, L., Yadav, S. S., Kim, J., Sepulveda, A. M., Sharp, M., Maitra, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811067116 · Cited by 334 · see citing works

Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features

Karamitopoulou, E. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0479-5 · Cited by 298 · see citing works

The Immune Revolution: A Case for Priming, Not Checkpoint

Vonderheide, R. H. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.008 · Cited by 294 · see citing works

Topography of cancer-associated immune cells in human solid tumors

Kather, J. N., Suarez‐Carmona, M., Charoentong, P., Weis, C., Hirsch, D. D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., et al. (2018) · eLife · doi:10.7554/elife.36967 · Cited by 277 · see citing works

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma

Qian, Z. R., Rubinson, D. A., Nowak, J. A., Morales-Oyarvide, V., Dunne, R. F., Kozak, M. M., Welch, M. W., Brais, L. K., Da Silva, A., Li, T., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3420 · Cited by 260 · see citing works

T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma

Stromnes, I. M., Hulbert, A., Pierce, R. H., Greenberg, P. D., & Hingorani, S. R. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0322 · Cited by 201 · see citing works

Neoadjuvant Selicrelumab, an agonist CD40 antibody, induces changes in the tumor microenvironment in patients with resectable pancreatic cancer

Byrne, K. T., Betts, C. B., Mick, R., Sivagnanam, S., Bajor, D. L., Laheru, D. A., Chiorean, E. G., O'Hara, M. H., Liudahl, S. M., Newcomb, C., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1047 · Cited by 199 · see citing works

High endothelial venules (HEVs) in human melanoma lesions

Martinet, L., Guellec, S. L., Filleron, T., Lamant, L., Meyer, N., Rochaix, P., Garrido, I., & Girard, J. (2012) · OncoImmunology · doi:10.4161/onci.20492 · Cited by 195 · see citing works

T-Distributed Stochastic Neighbor Embedding using a Barnes-Hut Implementation [R package Rtsne version 0.15]

Krijthe, J. H. (2018) · Cited by 188 · see citing works

Quantitative image analysis of immunohistochemical stains using a CMYK color model

Pham, N., Morrison, A. J., Schwock, J., Aviel‐Ronen, S., Iakovlev, V. V., Tsao, M., Ho, J., & Hedley, D. W. (2007) · Diagnostic Pathology · doi:10.1186/1746-1596-2-8 · Cited by 179 · see citing works

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

Parra, E. R., Villalobos, P. A., Behrens, C., Jiang, M., Pataer, A., Swisher, S. G., William, W. N., Zhang, J., Lee, J., Cascone, T., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0368-0 · Cited by 165 · see citing works

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

Väyrynen, S. A., Zhang, J., Yuan, C., Väyrynen, J. P., Costa, A. D., Williams, H. L., Morales‐Oyarvide, V., Lau, M. C., Rubinson, D. A., Dunne, R. F., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3141 · Cited by 159 · see citing works

Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project

Iacobuzio–Donahue, C. A. (2011) · Gut · doi:10.1136/gut.2010.236026 · Cited by 157 · see citing works

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Tsujikawa, T., Crocenzi, T. S., Durham, J. N., Sugar, E. A., Wu, A. A., Onners, B., Nauroth, J. M., Anders, R. A., Fertig, E. J., Laheru, D. A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3978 · Cited by 155 · see citing works

Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival

Masugi, Y., Abe, T., Ueno, A., Fujii‐Nishimura, Y., Ojima, H., Endo, Y., Fujita, Y., Kitago, M., Shinoda, M., Kitagawa, Y., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0291-z · Cited by 113 · see citing works

Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopesPreprint

Lin, J., Izar, B., Wang, S., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/151738 · Cited by 104 · see citing works

High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers

Banik, G. L., Betts, C. B., Liudahl, S. M., Sivagnanam, S., Kawashima, R., Cotechini, T., Larson, W., Goecks, J., Pai, S. I., Clayburgh, D. R., et al. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.05.039 · Cited by 80 · see citing works

PD-1: Its Discovery, Involvement in Cancer Immunotherapy, and Beyond

Ishida, Y. (2020) · Cells · doi:10.3390/cells9061376 · Cited by 60 · see citing works

The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma

Lee, A. T. J., Chew, W. H. W., Wilding, C. P., Guljar, N., Smith, M. J. F., Strauß, D., Fisher, C., Hayes, A. J., Judson, I. R., Thway, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50888-5 · Cited by 34 · see citing works

Clinical Management

White, R. R., & Lowy, A. M. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000291 · Cited by 17 · see citing works

The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray

Gruber, E. S., Oberhuber, G., Pils, D., Störk, T., Sinn, K., Gruber, S., Nica, R., Kolmer, D., Turner, S. D., Schlederer, M., et al. (2020) · Cancers · doi:10.3390/cancers12030563 · Cited by 9 · see citing works

An Omic and Multidimensional Spatial Atlas from Serial Biopsies of an Evolving Metastatic Breast CancerPreprint

Johnson, B., Creason, A., Stommel, J. M., Keck, J. M., Parmar, S., Betts, C. B., Blucher, A., Boniface, C., Bucher, E., Burlingame, E. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.03.408500 · Cited by 5 · see citing works

Pancreatic cancer: Advances and challenges

Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works

Applications of single-cell sequencing in cancer research: progress and perspectives

Lei, Y., Tang, R., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01105-2 · Cited by 597 · see citing works

Spatial profiling technologies illuminate the tumor microenvironment

Elhanani, O., Ben-Uri, R., & Keren, L. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.010 · Cited by 526 · see citing works

Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance

Sherman, M. H., & Beatty, G. L. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031621-024600 · Cited by 481 · see citing works

Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Reeves, J. W., Mohan, R., Drokhlyansky, E., Van Wittenberghe, N., Ashenberg, O., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01134-8 · Cited by 426 · see citing works

Single-cell spatial immune landscapes of primary and metastatic brain tumours

Karimi, E., Yu, M. W., Maritan, S. M., Perus, L. J. M., Rezanejad, M., Sorin, M., Dankner, M., Fallah, P., Doré, S., Zuo, D., et al. (2023) · Nature · doi:10.1038/s41586-022-05680-3 · Cited by 401 · see citing works

IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer

Caronni, N., Terza, F. L., Vittoria, F. M., Barbiera, G., Mezzanzanica, L., Cuzzola, V., Barresi, S., Pellegatta, M., Canevazzi, P., Dunsmore, G., et al. (2023) · Nature · doi:10.1038/s41586-023-06685-2 · Cited by 407 · see citing works

Single-cell spatial landscapes of the lung tumour immune microenvironment

Sorin, M., Rezanejad, M., Karimi, E., Fiset, B., Desharnais, L., Perus, L. J. M., Milette, S., Yu, M. W., Maritan, S. M., Doré, S., et al. (2023) · Nature · doi:10.1038/s41586-022-05672-3 · Cited by 375 · see citing works

Managing the TME to improve the efficacy of cancer therapy

Bilotta, M. T., Antignani, A., & FitzGerald, D. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954992 · Cited by 314 · see citing works

Therapeutic targeting of tumour myeloid cells

Barry, S. T., Gabrilovich, D. I., Sansom, O. J., Campbell, A. D., & Morton, J. P. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00546-2 · Cited by 305 · see citing works

The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer

Freed-Pastor, W. A., Lambert, L. J., Ely, Z. A., Pattada, N. B., Bhutkar, A., Eng, G., Mercer, K. L., Garcia, A. P., Lin, L., Rideout, W. M., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.007 · Cited by 273 · see citing works

Translational advances in pancreatic ductal adenocarcinoma therapy

Hosein, A. N., Dougan, S. K., Aguirre, A. J., & Maitra, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00349-2 · Cited by 249 · see citing works

Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer

Falcomatà, C., Bärthel, S., Schneider, G., Rad, R., Schmidt‐Supprian, M., & Saur, D. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0876 · Cited by 213 · see citing works

Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

Ruf, B., Bruhns, M., Babaei, S., Kedei, N., Ma, L., Revsine, M., Benmebarek, M.-R., Ma, C., Heinrich, B., Subramanyam, V., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.026 · Cited by 200 · see citing works

Neoadjuvant Selicrelumab, an agonist CD40 antibody, induces changes in the tumor microenvironment in patients with resectable pancreatic cancer

Byrne, K. T., Betts, C. B., Mick, R., Sivagnanam, S., Bajor, D. L., Laheru, D. A., Chiorean, E. G., O'Hara, M. H., Liudahl, S. M., Newcomb, C., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1047 · Cited by 199 · see citing works

Decoding the tumor microenvironment with spatial technologies

Walsh, L. A., & Quail, D. F. (2023) · Nature Immunology · doi:10.1038/s41590-023-01678-9 · Cited by 191 · see citing works

Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas

Kinker, G. S., Vitiello, G. A. F., Diniz, A. B., Cabral-Piccin, M. P., Pereira, P. H. B., Carvalho, M. L. R., Ferreira, W. A. S., Chaves, A. S., Rondinelli, A. J., Gusmão, A. F., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328697 · Cited by 130 · see citing works

Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

Wehrli, M., Guinn, S. R., Birocchi, F., Kuo, A., Sun, Y., Larson, R. C., Almazan, A. J., Scarfò, I., Bouffard, A. A., Bailey, S. R., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3841 · Cited by 127 · see citing works

Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer

Yousuf, S., Qiu, M., von Voithenberg, L. V., Hulkkonen, J., Mačinković, I., Schulz, A. R., Hartmann, D., Mueller, F., Mijatovic, M., Ibberson, D., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.05.036 · Cited by 116 · see citing works

Epithelial and stromal co-evolution and complicity in pancreatic cancer

Hingorani, S. R. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00530-w · Cited by 108 · see citing works

Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy

Bärthel, S., Falcomatà, C., Rad, R., Theis, F. J., & Saur, D. (2023) · Nature Cancer · doi:10.1038/s43018-023-00526-x · Cited by 101 · see citing works

Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

Gulhati, P., Schalck, A. P., Jiang, S., Shang, X., Wu, C., Hou, P., Ruiz, S. H., Soto, L. M. S., Parra, E. R., Ying, H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00500-z · Cited by 89 · see citing works

Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells

Halbrook, C. J., Thurston, G., Boyer, S., Anaraki, C., Jiménez, J. A., McCarthy, A., Steele, N. G., Kerk, S. A., Hong, H. S., Lin, L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00463-1 · Cited by 80 · see citing works

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Mi, H., Sivagnanam, S., Betts, C. B., Liudahl, S. M., Jaffee, E. M., Coussens, L. M., & Popel, A. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1190 · Cited by 78 · see citing works

Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer

Costa, A. D., Väyrynen, S. A., Chawla, A., Zhang, J., Väyrynen, J. P., Lau, M. C., Williams, H. L., Yuan, C., Morales-Oyarvide, V., Elganainy, D., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1125 · Cited by 75 · see citing works

Elimination of oncogenic Kras in genetic mouse models eradicates pancreatic cancer by inducing Fas-dependent apoptosis by CD8+ T cells

Mahadevan, K., LeBleu, V., Ramirez, E. V., Chen, Y., Li, B.-R., Sockwell, A. M., Gagea, M., Sugimoto, H., Sthanam, L. K., Tampe, D., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.07.025 · Cited by 67 · see citing works

Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy

Cotechini, T., Atallah, A., & Grossman, A. (2021) · Cells · doi:10.3390/cells10040960 · Cited by 69 · see citing works

Macrophages and T cells in metabolic disorder-associated cancers

Taranto, D., Kloosterman, D., & Akkari, L. (2024) · Nature Reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 67 · see citing works

Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity

Sorin, M., Karimi, E., Rezanejad, M., Yu, M. W., Desharnais, L., McDowell, S. A. C., Doré, S., Arabzadeh, A., Breton, V., Fiset, B., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005545 · Cited by 68 · see citing works

The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy

Hilmi, M., Delaye, M., Muzzolini, M., Nicolle, R., Cros, J. F., Hammel, P. R., Cardot‐Ruffino, V., & Neuzillet, C. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00207-8 · Cited by 71 · see citing works

Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma

Neuzillet, C., Nicolle, R., Raffenne, J., Tijeras‐Raballand, A., Brunel, A., Astorgues‐Xerri, L., Vacher, S., Arbaretaz, F., Fanjul, M., Hilmi, M., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6011 · Cited by 65 · see citing works

The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities

Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 69 · see citing works

Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms

Sivakumar, S., Jainarayanan, A., Arbe-Barnes, E. H., Sharma, P. K., Leathlobhair, M. N., Amin, S., Reiss, D. J., Heij, L. R., Hegde, S., Magen, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55424-2 · Cited by 67 · see citing works

The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions

Herting, C. J., Karpovsky, I., & Lesinski, G. B. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09988-w · Cited by 61 · see citing works

Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance

Zou, X., Lin, X., Cheng, H., Chen, Y., Wang, R., Ma, M., Liu, Y., Dai, Z., Tasiheng, Y., Yan, Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006698 · Cited by 56 · see citing works

Mapping cancer biology in space: applications and perspectives on spatial omics for oncology

Lee, S., Kim, G., Lee, J., Lee, A. C., & Kwon, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01941-z · Cited by 56 · see citing works

Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer

Boelaars, K., Kruijssen, L. J. W., Wang, D., de Winde, C. M., Rodríguez, E., Lindijer, D., Springer, B. O., Àvila, I. V. D. H., de Haas, A. M., Wehry, L., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007805 · Cited by 48 · see citing works

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model

Narayanan, J. S. S., Hayashi, T., Erdem, S., McArdle, S., Tiriac, H., Ray, P., Pu, M., Mikulski, Z., Miller, A. M., Messer, K. S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006133 · Cited by 45 · see citing works

Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer

Sanctis, F. D., Lamolinara, A., Boschi, F., Musiu, C., Caligola, S., Trovato, R., Fiore, A., Frusteri, C., Anselmi, C., Poffe, O., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003549 · Cited by 45 · see citing works

Deployable extrusion bioprinting of compartmental tumoroids with cancer associated fibroblasts for immune cell interactions

Mazzaglia, C., Sheng, Y., Rodrigues, L. N., Lei, I. M., Shields, J. D., & Huang, Y. Y. S. (2023) · Biofabrication · doi:10.1088/1758-5090/acb1db · Cited by 44 · see citing works

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma

Croft, W. D., Pearce, H., Margielewska‐Davies, S., Lim, L., Nicol, S. M., Zayou, F., Blakeway, D., Marcon, F., Powell-Brett, S. F., Mahon, B. S., et al. (2023) · eLife · doi:10.7554/elife.86125 · Cited by 43 · see citing works

Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer

Link, J. M., Eng, J. R., Pelz, C., Hawthorne, K., Worth, P. J., Sivagnanam, S., Keith, D., Owen, S., Langer, E. M., Grossblatt-Wait, A., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00881-3 · Cited by 44 · see citing works

Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer

Karamitopoulou, E., Wenning, A. S., Acharjee, A., Zlobec, I., Aeschbacher, P., Perren, A. A., & Gloor, B. (2023) · Gut · doi:10.1136/gutjnl-2022-329371 · Cited by 42 · see citing works

Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology

Mi, H., Sivagnanam, S., Ho, W. J., Zhang, S., Bergman, D. R., Deshpande, A. M., Baras, A. S., Jaffee, E. M., Coussens, L. M., Fertig, E. J., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae421 · Cited by 38 · see citing works

Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression

Turlej, E., Domaradzka, A., Radzka, J., Drulis‐Fajdasz, D., Kulbacka, J., & Gizak, A. (2025) · Cells · doi:10.3390/cells14060403 · Cited by 42 · see citing works

Peritumoral TIGIT+CD20+ B cell infiltration indicates poor prognosis but favorable adjuvant chemotherapeutic response in gastric cancer

Liu, H., Wu, J., Xu, X., Wang, H., Zhang, C., Yin, S., & He, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108735 · Cited by 36 · see citing works

Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer

Li, Y., Chang, R. B., Stone, M. L., Delman, D., Markowitz, K., Xue, Y., Coho, H., Herrera, V. M., Li, J. H., Zhang, L., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101397 · Cited by 35 · see citing works

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Oberstein, P. E., Costa, A. D., Kawaler, E. A., Cardot‐Ruffino, V., Rahma, O. E., Beri, N., Singh, H., Abrams, T. A., Biller, L. H., Cleary, J. M., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-1073 · Cited by 35 · see citing works

Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer

Sussman, J., Kim, N., Kemp, S. B., Traum, D., Katsuda, T., Kahn, B., Xu, J., Kim, I., Eskandarian, C., Delman, D., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2352 · Cited by 32 · see citing works

Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems

Lencioni, G., Gregori, A., Toledo, B., Rebelo, R., Immordino, B., Amrutkar, M., Xavier, C. P. R., Kocijancic, A., Pandey, D. P., Perán, M., et al. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.002 · Cited by 31 · see citing works

Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer

Blise, K. E., Sivagnanam, S., Betts, C. B., Betre, K., Kirchberger, N. C., Tate, B. J., Furth, E. E., Costa, A. D., Nowak, J. A., Wolpin, B. M., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0873 · Cited by 30 · see citing works

CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges

Abken, H. (2025) · Nature reviews: Gastroenterology & hepatology · doi:10.1038/s41575-025-01062-y · Cited by 27 · see citing works

Forecasting cancer: from precision to predictive medicine

Fertig, E. J., Jaffee, E. M., Macklin, P., Stearns, V., & Wang, C. (2021) · Med · doi:10.1016/j.medj.2021.08.007 · Cited by 26 · see citing works

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

Bansod, S., Dodhiawala, P. B., & Lim, K. (2021) · Cancers · doi:10.3390/cancers13215481 · Cited by 26 · see citing works

Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer

Stump, C. T., Roehle, K., Manjarrez‐Orduño, N., & Dougan, S. K. (2021) · Open Biology · doi:10.1098/rsob.210245 · Cited by 28 · see citing works

Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma

Wattenberg, M. M., Colby, S., Garrido‐Laguna, I., Xue, Y., Chang, R. B., Delman, D., Lee, J., Affolter, K. E., Mulvihill, S. J., Beg, M. S., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.013 · Cited by 24 · see citing works

PD-1/PD-L1–Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgroups

Karamitopoulou, E., Andreou, A., de Mortanges, A. P., Tinguely, M., Gloor, B., & Perren, A. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0144 · Cited by 24 · see citing works

Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer

Du, W., di Magliano, M. P., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682217 · Cited by 22 · see citing works

Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer

Karamitopoulou, E., Wenning, A. S., Acharjee, A., Aeschbacher, P., Marinoni, I., Zlobec, I., Gloor, B., & Perren, A. A. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0368 · Cited by 23 · see citing works

KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer

Suzuki, T., Masugi, Y., Inoue, Y., Hamada, T., Tanaka, M. H., Takamatsu, M., Arita, J., Kato, T., Kawaguchi, Y., Kunita, A., et al. (2022) · Cancer Science · doi:10.1111/cas.15398 · Cited by 21 · see citing works

Application of spatial and single-cell omics in tumor immunotherapy biomarkers

Zhang, C., Feng, H.-R., Zhu, J., & Hong, W. (2025) · LabMed discovery. · doi:10.1016/j.lmd.2025.100076 · Cited by 20 · see citing works

Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment

Finan, J. M., Guo, Y., Goodyear, S. M., & Brody, J. R. (2024) · JCO oncology advances. · doi:10.1200/oa-24-00050 · Cited by 20 · see citing works

The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice

Li, Q., Yang, C., Li, J., Wang, R., Min, J., Song, Y., & Su, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06778-8 · Cited by 19 · see citing works

Multiomics Empowers Predictive Pancreatic Cancer Immunotherapy

Montagne, J. M., Jaffee, E. M., & Fertig, E. J. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200660 · Cited by 18 · see citing works

“Hurdles race for CAR T ‐cell therapy in digestive tract cancer”

Kronig, M.-N., Wehrli, M., Salas‐Benito, D., & Maus, M. V. (2023) · Immunological Reviews · doi:10.1111/imr.13273 · Cited by 18 · see citing works

Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer

Oyama, K., Nakata, K., Tsutsumi, C., Hayashi, M., Zhang, B., Mochida, Y., Shinkawa, T., Hirotaka, K., Zhong, P., Date, S., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0830 · Cited by 18 · see citing works

Spatial Profiles of Intratumoral PD-1+ Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma

Yoshimura, K., Tsujikawa, T., Mitsuda, J., Ogi, H., Saburi, S., Ohmura, G., Arai, A., Shibata, S., Thibault, G., Chang, Y. H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769534 · Cited by 17 · see citing works

Updates in Immunotherapy for Pancreatic Cancer

Chick, R. C., & Pawlik, T. M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216419 · Cited by 16 · see citing works

Emerging Prognostic and Predictive Factors in Pancreatic Cancer

Karamitopoulou, E. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100328 · Cited by 15 · see citing works

Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer

Monte, L. B. D., Clemente, F., Ruggiero, E., Pini, R., Ceraolo, M. G., Lena, M. S., Balestrieri, C., Lazarevic, D., Belfiori, G., Crippa, S., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104819 · Cited by 15 · see citing works

Spatial immune composition of tumor microenvironment in patients with pancreatic cancer

Zwart, E. S., van Ee, T., Affandi, A. J., Boyd, L. N. C., Rodríguez, E., den Haan, J. M. M., Sarasqueta, A. F., van Grieken, N. C. T., Meijer, L. L., van Kooyk, Y., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03573-6 · Cited by 15 · see citing works

Determinants of Homologous Recombination Deficiency in Pancreatic Cancer

Wattenberg, M. M., & Reiss, K. A. (2021) · Cancers · doi:10.3390/cancers13184716 · Cited by 15 · see citing works

MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

Ghukasyan, R., Liang, K., Chau, K., Li, L., Chan, C., Abt, E. R., Le, T. M., Park, J. Y., Wu, N., Premji, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3322 · Cited by 14 · see citing works

Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer

Gorchs, L., Moro, C. F., Asplund, E., Oosthoek, M., Solders, M., Ghorbani, P., Sparrelid, E., Rangelova, E. B., Löhr, M. J., & Kaipe, H. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0405 · Cited by 14 · see citing works

Mapping spatial heterogeneity in gastric cancer microenvironment

Wang, B., Song, B., Li, Y., Zhao, Q., & Tan, B. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116317 · Cited by 14 · see citing works

MIM-CyCIF: masked imaging modeling for enhancing cyclic immunofluorescence (CyCIF) with panel reduction and imputation

Sims, Z., Mills, G. B., & Chang, Y. H. (2024) · Communications Biology · doi:10.1038/s42003-024-06110-y · Cited by 13 · see citing works

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma

Ma, H., Chen, X., Mo, S., Mao, X., Chen, J., Liu, Y., Lu, Z., Yu, S., & Chen, J. (2023) · Theranostics · doi:10.7150/thno.86547 · Cited by 13 · see citing works

Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment

Arnold, F., Vecchio, A. D., Hussain, Z., & Sherman, M. H. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00905-9 · Cited by 14 · see citing works

Identifying the Spatial Architecture That Restricts the Proximity of CD8+ T Cells to Tumor Cells in Pancreatic Ductal Adenocarcinoma

Xia, Y., Ma, J., Yang, X., Liu, D., Zhu, Y., Zhao, Y., Fei, X., Xu, D., & Dai, J. (2024) · Cancers · doi:10.3390/cancers16071434 · Cited by 12 · see citing works

From surfing to diving into the tumor microenvironment through multiparametric imaging mass cytometry

Erreni, M., Fumagalli, M. R., Marozzi, M., Leone, R., Parente, R., D’Anna, R., & Doni, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544844 · Cited by 12 · see citing works

PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients

Yang, X., Wang, G., Song, Y., Zhuang, T., Li, Y., Xie, Y., Fei, X., Zhao, Y., Xu, D., & Hu, Y. (2023) · Cancers · doi:10.3390/cancers15051389 · Cited by 12 · see citing works

The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities

Herpels, M., Ishihara, J., & Sadanandam, A. (2023) · The Journal of Pathology · doi:10.1002/path.6171 · Cited by 11 · see citing works

Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma

Groß, N., Zhang, Z., Mitchell, J. T., Charmsaz, S., Hernandez, A., Coyne, E. M., Shin, S. M., Carvajal, D. C. V., Sidiropoulos, D. N., Cho, Y., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179292 · Cited by 11 · see citing works

Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models

Aksoy, S. A., Earl, J., Grahovac, J., Karakaş, D., Lencioni, G., Sığırlı, S., & Bijlsma, M. F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.003 · Cited by 11 · see citing works

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

Ponzo, M., Debesset, A., Cossutta, M., Chalabi‐Dchar, M., Houppe, C., Pilon, C., Nicolás‐Boluda, A., Meunier, S., Raineri, F., Thiolat, A., et al. (2022) · Cancers · doi:10.3390/cancers14174265 · Cited by 11 · see citing works

Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Sinha, M., Betts, C. B., Zhang, L., Griffith, M. J., Solman, I. G., Chen, B., Liu, E. V., Tamaki, W., Stultz, J., Marquez, J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005425 · Cited by 11 · see citing works

3D multiplexed tissue imaging reconstruction and optimized region of interest (ROI) selection through deep learning model of channels embedding

Burlingame, E. A., Ternes, L., Lin, J., Chen, Y.-A., Kim, E. N., Gray, J. W., Santagata, S., Sorger, P. K., & Chang, Y. H. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1275402 · Cited by 10 · see citing works

Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma

Li, X., Hou, W., Xiao, C., Yang, H., Zhao, C., & Cao, D. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00970-6 · Cited by 10 · see citing works

Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies

Caligola, S., Sanctis, F. D., Canè, S., & Ugel, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.867880 · Cited by 10 · see citing works

Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability

Mukherjee, S., Antony, A., Patnam, N. G., Trivedi, K. H., Karbhari, A., Bhinder, K. K., Zarrintan, A., Fletcher, J. G., Truty, M. J., Johnson, M. P., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337266 · Cited by 9 · see citing works

Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC

Musiu, C., Lupo, F., Agostini, A., Lionetto, G., Bevere, M., Paiella, S., Carbone, C., Corbo, V., Ugel, S., & Sanctis, F. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341079 · Cited by 9 · see citing works

Pancreatic ductal adenocarcinoma holds unique features to form an immunosuppressive microenvironment: a narrative review

Zhou, Q., Chen, D., Zhang, J., Xiang, J.-F., Zhang, T., Wang, H., & Zhang, Y. (2022) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000109 · Cited by 9 · see citing works

Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer

Digomann, D., Heiduk, M., Reiche, C., Glück, J., Kahlert, C., Mirtschink, P., Klimová, A., Bösch, F., Tonn, T., Gaedcke, J., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00459-9 · Cited by 9 · see citing works

Galaxy-ME: A Web-based Software Resource for Interactive Analysis of Multiplex Tissue Imaging DatasetsPreprint

Creason, A., Watson, C., Gu, Q., Persson, D., Sargent, L., Chen, Y., Lin, J., Sivagnanam, S., Wünnemann, F., Nirmal, A. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.18.504436 · Cited by 8 · see citing works

Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma

Gao, Z., Azar, J. H., Zhu, H., Williams-Perez, S. M., Kang, S. W., Marginean, C. E., Rubinstein, M. P., Makawita, S., Lee, H., & Camp, E. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324093 · Cited by 7 · see citing works

Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies

Srinivasan, D., Gout, J., Kleger, A., & Roger, É. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115697 · Cited by 7 · see citing works

A Randomized Phase II Study: CRS207/GVAX plus Anti–PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC

Bever, K. M., Huff, A. L., Danilova, L., Wetzel, M., Tandurella, J. A., Durham, J. N., Wang, T., Lee, J. W., Coyne, E. M., Montagne, J. M., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0545 · Cited by 7 · see citing works

Bispecific T-cell engager therapy for gastrointestinal cancers

Burton, K. A., Metropulos, A. E., Kamath, S. D., Munshi, H. G., & Principe, D. R. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218417 · Cited by 7 · see citing works

Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer

Malchiodi, Z. X., Lekan, A. A., Suter, R. K., Deshpande, A. M., Arslan, S., Lee, A., Wang, N., Peran, I., Harris, B. T., Duttargi, A., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-1481 · Cited by 7 · see citing works

Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanoma

Femel, J., Hill, C. M., Bochaca, I. I., Booth, J. L., Asnaashari, T. G., Steele, M. M., Moshiri, A. S., Do, H., Zhong, J., Osman, I., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328602 · Cited by 7 · see citing works

Unique Spatial Immune Profiling in Pancreatic Ductal Adenocarcinoma with Enrichment of Exhausted and Senescent T Cells and Diffused CD47-SIRPα Expression

Papalampros, A., Vailas, M. G., Ntostoglou, K., Chiloeches, M. L., Sakellariou, S., Chouliari, N. V., Samaras, M. G., Veltsista, P. D., Theodorou, S. D. P., Margetis, A., et al. (2020) · Cancers · doi:10.3390/cancers12071825 · Cited by 25 · see citing works

Abstract PR016: High-plex spatial phenotyping resolves immune organization in pancreatic ductal adenocarcinoma

Olgun, D. G., Gong, D. H., Pereira, G. F. P. M., Cao, J., Kaneko, O., Wang, P., Jhaveri, N., Hou, Y., Cheikh, B. B., Ji, H., et al. (2026) · Cancer Research · doi:10.1158/1538-7445.pancreatic26-pr016

Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer

Yousuf, S., Qiu, M., von Voithenberg, L. V., Hulkkonen, J., Mačinković, I., Schulz, A. R., Hartmann, D., Mueller, F., Mijatovic, M., Ibberson, D., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.05.036 · Cited by 116 · see citing works

Neoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment

Sidiropoulos, D. N., Shin, S. M., Wetzel, M., Girgis, A. A., Bergman, D. R., Danilova, L., Perikala, S., Shu, D. H., Montagne, J. M., Deshpande, A. M., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0387 · Cited by 16 · see citing works

Spatial Heterogeneity of Immune Drivers Coordinates the Organisation of Antitumor Immunity in Pancreatic Cancer, Affecting Patient Outcome

Wenning, A. S., Aeschbacher, P., Gloor, B., Karamitopoulou, E., Perren, A. A., & Marinoni, I. (2024) · British journal of surgery · doi:10.1093/bjs/znae118.038 · Cited by 1 · see citing works